GlassScriptPhysician profile
Elizabeth B Bleecker
NPI 1265693774
$1,801.59
in general payments reported to CMS, 2019-2025
27 companies · $82.58 in 2025
The $82.58 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.94 · 2020: $119 · 2021: $486 · 2022: $468 · 2023: $269 · 2024: $299 · 2025: $82.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.32 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $448.72 | 2021-2024 | Ova1 |
| Abbvie INC. | $333.12 | 2021-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $126.53 | 2019-2023 | |
| Biogen, INC. | $114.59 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $86.28 | 2019-2025 | Endosee, Ally II Ups |
| Bayer Healthcare Pharmaceuticals INC. | $78.15 | 2021-2022 | |
| Organon LLC | $77.28 | 2022-2024 | Nexplanon |
| Channel Medsystems, INC. | $71.52 | 2023 | |
| Exeltis, USA INC. | $54.18 | 2020-2023 | Slynd |
| Caldera Medical, INC | $41.02 | 2021 | |
| Pfizer INC. | $39.65 | 2022-2024 | |
| Avion Pharmaceuticals | $36.93 | 2020-2021 | |
| Hologic Sales and Service, LLC | $32.31 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $30.00 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $28.97 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $26.82 | 2021 | |
| Boston Scientific Corporation | $23.55 | 2022 | |
| Merck Sharp & Dohme LLC | $21.13 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| Mayne Pharma Commercial LLC | $19.35 | 2021 | |
| Becton, Dickinson and Company | $17.61 | 2020 | |
| Smith+Nephew, INC. | $16.91 | 2025 | Pico |
| Mylan Pharmaceuticals INC. | $15.62 | 2020 | |
| Medtronic, INC. | $15.34 | 2023 | Truclear |
| Allergan, INC. | $13.79 | 2019 | |
| Agile Therapeutics, INC. | $12.13 | 2021 | |
| Olympus America INC. | $11.88 | 2022 | |
| Meditrina | $8.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Bleecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.